President Trump's Medicare Changes: 4 Things You Should Know

Source The Motley Fool

President Donald Trump didn't wait long in his second term to begin shaking things up in Washington, D.C. In less than two weeks back in the White House, Trump delivered upheaval in multiple areas, including immigration enforcement, federal grants, and even the names of geographical locations.

But has he done anything related to Medicare? Actually, yes. Here are four things you need to know about changes made by Trump that impact the popular federal program since Inauguration Day.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »

President Trump standing before a White House podium.

Image source: Official White House photo by D. Myles Cullen.

1. Prescription drug prices aren't being increased

One of the many executive orders on Trump's first day back in office was to rescind several executive orders previously issued by former President Joe Biden. Included in that group was Executive Order 14087 signed by Biden on Oct. 14, 2022, with the stated goal of lowering prescription drug costs for Americans.

At first glance, it might seem that Trump's action increases prescription drug prices. Rep. Jared Golden, D-Maine, posted on X, "At a time when we should be lowering prescription drug costs, this order by President Trump closes the door to $2 generics and cuts the ACA enrollment window for uninsured Americans."

But did Trump's executive order actually raise prescription drug prices for Medicare beneficiaries or anyone else? No, current drug prices won't be affected by this move. The Inflation Reduction Act of 2022, which was signed into law by Biden, phases in a cap for out-of-pocket costs for Medicare beneficiaries and established a $35 per-month cap on insulin. Overturning these provisions would require an act of Congress.

2. Trump's executive order could impact initiatives to lower drug prices in the future

There is more to the story, though. Former President Biden's Executive Order 14087 directed the Department of Health and Human Services (HHS) to study potential ways to reduce drug prices. One of the ideas floated to accomplish this goal (as mentioned in Rep. Golden's social media post but not included in the text of the executive order) was to place a $2 per-month out-of-pocket cap on some generic drugs.

HHS didn't complete the initiative to lower drug prices before Biden left office. With Trump's executive order rescinding Biden's executive order, the department's efforts to research how to lower Medicare drug prices will come to a screeching halt.

We'll never know if Trump's action thwarted future changes that would have reduced drug prices for Medicare beneficiaries. However, during his first term, Trump supported policies that would lower Medicare drug prices.

3. The president's move creates some uncertainty for Medicare

The rescission of Executive Order 14087 without a new executive order directing HHS to explore ways to lower Medicare costs does create some uncertainty for the program. However, the language of Trump's executive order set the stage for future actions. It read: "The revocations within this order will be the first of many steps the United States Federal Government will take to repair our institutions and our economy."

4. Medicare appears to be in capable hands with the new Acting HHS Secretary

Trump issued another directive that immediately impacted Medicare. He named Dorothy Fink as the Acting HHS Secretary. Medicare appears to be in capable hands with Fink at the helm of its parent agency.

Fink earned her MD degree from Georgetown University School of Medicine. She is board-certified in endocrinology, internal medicine, and pediatrics. Trump appointed her as the deputy assistant secretary for women's health in his first presidential term. Before taking the helm as acting HHS Secretary, she served as the director of HHS' Office on Women's Health.

It remains to be seen how long Fink will lead HHS, though. Trump nominated Robert F. Kennedy, Jr. to be the HHS Secretary. Kennedy faced Senate committee confirmation hearings last week.

The $22,924 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income. For example: one easy trick could pay you as much as $22,924 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Simply click here to discover how to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Dogecoin Whales Go On 270 Million DOGE Buying Spree As Crash Provides Low EntryWhile widespread liquidations would be expected from the recent DOGE price crash, Dogecoin whales have embraced the downturn as a prime opportunity.
Author  Bitcoinist
Dec 26, 2024
While widespread liquidations would be expected from the recent DOGE price crash, Dogecoin whales have embraced the downturn as a prime opportunity.
placeholder
Could PEPE become the next Dogecoin?PEPE is following the path of Dogecoin, which it might replace at some level. With Elon Musk’s endorsement and the community’s support, PEPE is ready for the 2025 rally, which looks eerily similar to Dogecoin in 2021. Dogecoin was initiated in 2013 as a joke based on the “Doge” meme, which had a picture of […]
Author  Cryptopolitan
Jan 03, Fri
PEPE is following the path of Dogecoin, which it might replace at some level. With Elon Musk’s endorsement and the community’s support, PEPE is ready for the 2025 rally, which looks eerily similar to Dogecoin in 2021. Dogecoin was initiated in 2013 as a joke based on the “Doge” meme, which had a picture of […]
placeholder
XRP Price Prediction: Wall Street Analyst Predict Much Lower However Expect A Surge Within Ethereum Altcoin RollblockCryptocurrency remains unparalleled in its ability to generate rapid 5-10x returns during a bull market, making it a prime opportunity for early investors. As altcoin season draws closer, the next couple of weeks could mark the final chance to accumulate high-potential safety net assets like XRP at discounted prices before momentum inevitably shifts upward and […]
Author  FXStreet
Jan 30, Thu
Cryptocurrency remains unparalleled in its ability to generate rapid 5-10x returns during a bull market, making it a prime opportunity for early investors. As altcoin season draws closer, the next couple of weeks could mark the final chance to accumulate high-potential safety net assets like XRP at discounted prices before momentum inevitably shifts upward and […]
placeholder
Japanese Yen remains on the front foot against USD after Tokyo CPIThe Japanese Yen (JPY) attracts buyers for the third straight day on Friday and remains close to over a one-month high touched against its American counterpart earlier this week.
Author  FXStreet
Jan 31, Fri
The Japanese Yen (JPY) attracts buyers for the third straight day on Friday and remains close to over a one-month high touched against its American counterpart earlier this week.
placeholder
ASML Crushes Q4 2024 Earnings: What are the Key Takeaways for Investors?In a big week for Big Tech earnings, semiconductor equipment giant ASML Holding NV (NASDAQ: ASML) reported its latest Q4 2024 earnings on Wednesday (29 January) before the market open in the US.ASML e
Author  TradingKey
Jan 31, Fri
In a big week for Big Tech earnings, semiconductor equipment giant ASML Holding NV (NASDAQ: ASML) reported its latest Q4 2024 earnings on Wednesday (29 January) before the market open in the US.ASML e
goTop
quote